Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer

Identifying and targeting specific oncogenic drivers has become standard of care in the routine management of patients with lung cancer. Research is ongoing to expand the number of drug targets that can offer clinically meaningful outcomes. Rearranged during transfection (RET) fusions are the latest...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Leary, Connor, Xu, Wen, Pavlakis, Nick, Richard, Derek, O’Byrne, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562639/
https://www.ncbi.nlm.nih.gov/pubmed/31058838
http://dx.doi.org/10.3390/cancers11050620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562639/
https://www.ncbi.nlm.nih.gov/pubmed/31058838
http://dx.doi.org/10.3390/cancers11050620

Ejemplares similares